No Data
No Data
No Data
No Data
No Data
Versor Investments LP Takes $47.04 Million Position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
Versor Investments LP bought a new stake in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) in the second quarter, according to the company in its most recent Form 13F filing with the Se
Financial News LiveOct 10, 2022 00:21
Brinker Capital Investments LLC Buys Shares of 3,167 Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
Brinker Capital Investments LLC bought a new stake in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) in the second quarter, according to the company in its most recent Form 13F filing w
Defense WorldOct 9, 2022 16:51
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Shares Sold by Amalgamated Bank
Amalgamated Bank cut its position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) by 7.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm
Defense WorldOct 9, 2022 16:11
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Given Average Rating of "Hold" by Brokerages
Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) has received an average rating of "Hold" from the twelve brokerages that are covering the stock, Marketbeat reports. Eight research analys
Defense WorldSep 19, 2022 14:21
ProShare Advisors LLC Sells 3,250 Shares of Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
ProShare Advisors LLC reduced its position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) by 19.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 13,760 shares of th
Defense WorldSep 5, 2022 16:11
Turning Point Therapeutics (NASDAQ:TPTX) Sees Strong Trading Volume
Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) shares saw unusually-high trading volume on Tuesday . Approximately 50,472 shares were traded during trading, a decline of 94% from the pr
Defense WorldAug 18, 2022 17:02
No Data
No Data